Active Ingredient: TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: TENOFOVIR DISOPROXIL FUMARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211337
Product Number: 001
Approval Date: Mar 2, 2023
Applicant Holder Full Name: REYOUNG CORPORATION
Marketing Status:
Prescription
Patent and Exclusivity Information